Nektar Therapeutics (Nasdaq: NKTR) today announced that Novartis AG (NYSE: NVS) has agreed to acquire from Nektar specific pulmonary delivery ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE